2Seventy Bio Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
2Seventy Bio Inc
TickerTSVT
CIK #0001860782
CUSIP901384107
SectorLife Sciences - Pharmaceutical Preparations
Address60 Binney Street, Cambridge, MA 02210
Source [EDGAR]
CIK Filing 2011 - 2024
[0001860782] 10-K
[0001860782] 10-Q
[0001860782] 3
[0001860782] 4
[0001860782] 8-K
[0001860782] D
[0001860782] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Millennium Management LLC 2Seventy Bio Inc [2023-05-15] 5.0
Citadel Advisors LLC 2Seventy Bio Inc [2023-05-01] 4.1
Baker Bros Advisors LP 2Seventy Bio Inc [2023-02-14] 5.4
BlackRock Inc 2Seventy Bio Inc [2023-02-03] 7.9
Vanguard Group Inc 2Seventy Bio Inc [2022-02-09] 7.96
BlackRock Inc 2Seventy Bio Inc [2022-02-07] 6.9
Wellington Management Group LLP 2Seventy Bio Inc [2022-02-04] 8.94
BlackRock Inc 2Seventy Bio Inc [2022-02-04] 0.0
State Street Corp 2Seventy Bio Inc [2022-01-10] 10.12
EcoR1 Capital LLC 2Seventy Bio Inc [2021-11-16] 8.1
Form 3/4/5 Filer 2011 - 2024
Wei Lin
2seventy bio, Inc.
Baird William D III
Heffron Nicola
Leschly Nick
Gregory Philip D
Ibrahim Ramy
Glickman Sarah JS
Lynch Daniel
Torres Denice
Maus Marcela V.
Sellers William R.
bluebird bio, Inc.
Form 13F Holdings
Firm Period DFND Voting Shares
Kynam Capital Management LP [2023-03-31] SOLE 3,738,972.0 3,738,972.0
BlackRock Inc. [2023-03-31] SOLE 3,072,417.0 3,160,523.0
State Street Corp [2023-03-31] DFND 3,095,220.0 3,147,389.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,836,820.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 2,769,442.0
Baker Bros Advisors LP [2023-03-31] SOLE 2,497,526.0 2,497,526.0
Citadel Advisors LLC [2023-03-31] DFND 2,394,186.0 2,394,186.0
OrbiMed Advisors LLC [2023-03-31] DFND 667,300.0 2,391,628.0
Casdin Capital LLC [2023-03-31] SOLE 2,023,913.0 2,023,913.0
Millennium Management LLC [2023-03-31] SOLE 1,942,618.0 1,942,618.0
Goldman Sachs Group Inc [2023-03-31] DFND 1,739,162.0 1,747,522.0
JPMorgan Chase & Co [2023-03-31] DFND 1,361,465.0 1,583,681.0
Newtyn Management LLC [2023-03-31] SOLE 1,505,000.0 1,505,000.0
Balyasny Asset Management LP [2023-03-31] SOLE 1,436,398.0 1,436,398.0
Bain Capital Life Sciences Investors, LLC [2023-03-31] SOLE 1,408,901.0 1,408,901.0
Morgan Stanley [2023-03-31] DFND 1,112,691.0 1,165,326.0
ExodusPoint Capital Management LP [2023-03-31] SOLE 1,029,040.0 1,029,040.0
Credit Suisse AG [2023-03-31] DFND 1,007,545.0 1,017,974.0
Iron Triangle Partners LP [2023-03-31] SOLE 868,939.0 868,939.0
CHI Advisors LLC [2023-03-31] DFND 855,000.0 855,000.0
Artal Group S.A. [2023-03-31] DFND 750,000.0 750,000.0
Geode Capital Management LLC [2023-03-31] DFND 741,472.0 741,472.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 119,448.0 590,089.0
Sectoral Asset Management Inc [2023-03-31] SOLE 214,919.0 476,000.0
Boxer Capital, LLC [2023-03-31] OTR 459,836.0 459,836.0
Bank of America Corp /DE/ [2023-03-31] DFND 9,522.0 399,936.0
Barclays PLC [2023-03-31] SOLE 394,126.0 394,126.0
Deep Track Capital LP [2023-03-31] SOLE 350,000.0 350,000.0
Northern Trust Corp [2023-03-31] DFND 16,466.0 348,916.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 319,993.0 319,993.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com